A new intramuscular (IM) injection option of Biogen’s Plegridy (peginterferon beta-1a) has been approved by the European Commission for the treatment of relapsing-remitting multiple sclerosis (MS).

Part 1 of this two-part series on injection techniques describes the evidence base and procedure for administering an intramuscular injection. This updates an article previously published in 2018.

In a recent study published in the journal PNAS, researchers demonstrated higher comparative efficacy of the intranasal (IN) route of coronavirus disease 2019 (COVID-19) vaccine administration versus ...

Routes of drug administration refer to the right path or the required route through which a drug has to be administered into the body to obtain maximum benefit. A drug administered into the body ...

In patients on hemodialysis with a history of failure to respond to hepatitis B vaccination, intradermal revaccination is more effective than repeat intramuscular vaccination. Intradermal vaccine ...